The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer
Xin Jin(Central South University), Pingbo Chen(Hunan Normal University), Yuan Wu(UPMC Hillman Cancer Center), Qingqing Mo(Tongji Hospital), Yu Zhang(Wannan Medical College), Jing Li(First Affiliated Hospital of Zhengzhou University), Yue Gao(Guangdong Provincial Center for Disease Control and Prevention), Ding Ma(Cancer Foundation of China), Qinglei Gao(Tongji Hospital)
Cited by 48
Related Papers
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212